Another Indian lab recalling eye drops following recalls in October and instances of blindness caused by other imports from India in March.
In the wake of the COVID pandemic, consumers have become painfully aware of America’s heavy dependence on imports. The recent Amoxicillin shortage in hospitals has made this particularly clear since the United States is now highly reliant on imported antibiotics and other lifesaving medications. The United States is so deep in the hole when it…
CPA Applauds Congresswoman Tenney’s PILLS Act, Legislation to Boost U.S. Domestic Production of Generic Medicines
WASHINGTON — The Coalition for a Prosperous America (CPA) today applauded the introduction of the Producing Incentives for Long-term Production of Lifesaving Supply of Medicines (PILLS) Act by Congresswoman Claudia Tenney (R-NY) which would incentivize the strategic reshoring of U.S. domestic production of generic medicines with a domestic production-based tax credit, domestic content bonus credit,…
Trump’s call to reshore pharmaceutical production, especially critical medicine in short supply, will set the table for other presidential candidates. Reshoring America’s medicine supply chain is increasingly mainstream, and an easy sell to voters.
A Chinese cancer drug maker that has not been inspected by the FDA since 2018 is selling chemotherapy drugs to the U.S. due to shortages. When will the U.S. meet its critical medication needs?
The balance between scarcity and supply favors supply, even if that means importing drugs from labs the FDA has not inspected.
The U.S. is increasingly reliant on imported drugs from uninspected labs. It’s not safe. What can be done about it?
A Senate hearing on pharmaceutical shortages discusses America’s dependence on India and China, and what can be done to reshore.
America needs to be prepared for the next health crisis WASHINGTON — The Coalition for a Prosperous America (CPA) urged the U.S. Trade Representative (USTR) Katherine Tai to reimpose tariffs on imports of personal protective equipment (PPE). Specifically, CPA opposes the continuation of COVID-related exclusions for 81 medical care products. In a submission to Ambassador…
The Senate Commerce Committee takes the little known, and even less understood, Pharmacy Benefit Manager industry to task for high drug costs.